Phase III randomised trial of adjuvant chemotherapy with cisplatin plus docetaxel versus cisplatin plus gemcitabine in resected non-small cell bronchial carcinoma with quality of life as the primary objective;Essai randomisé de phase III de chimiothérapie adjuvante par CDDP/docetaxel versus CDDP/gemcitabine dans les cancers bronchiques non à petites cellules réséqués avec la qualité de vie comme objectif principal

Revue des Maladies Respiratoires

Volumn 23, Issue 5 C1, 2006, Pages 489-496

  Barlesi F ^a,b,c   Barrau, K ^b   Doddoli, C ^a   Morange, S ^a   Thirion, X ^a   Astoul, P ^a   Auquier, P ^b   Thomas, P ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Faculté de Médecine Université de la Méditerranée   (France)

^c HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Adjuvant chemotherapy; Docetaxel; Gemcitabine; Lung cancer; Quality of life; Thoracic surgery

Indexed keywords

CISPLATIN; DEXAMETHASONE; DEXCHLORPHENIRAMINE; DOCETAXEL; GEMCITABINE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RANITIDINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; FEBRILE NEUTROPENIA; FEMALE; HEALTH CARE COST; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OPEN STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT FORM 36;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COST-BENEFIT ANALYSIS; DEOXYCYTIDINE; FEMALE; FRANCE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE; TAXOIDS;

EID: 33846820137     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(06)71825-3     Document Type: Article

References (41)

1. Spiro SG, Porter JC : Lung cancer: where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002 ; 166 : 1166-96.
2. Mountain CF : Revisions in the International System for Staging Lung Cancer. Chest 1997 ; 111 : 1710-7.
3. Thomas P, Doddoli C, Thirion X, Ghez O, Payan-Defais MJ, Giudicelli R, Fuentes P : Stage I non-small cell lung cancer: a pragmatic approach to prognosis after complete resection. Ann Thorac Surg 2002 ; 73 : 1065-70.
4. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J, Olazabal A, Canela M, Ariza A, Skace ZI, Morera-Prat J, and Abad A : A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994 ; 330 : 153-8.
5. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M, Atkinson EN, Hong WK : A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994 ; 86 : 673-80.
6. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna J : Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992 ; 53 : 992-8.
7. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C : French Thoracic Cooperative Group: Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 2002 ; 20 : 247-53.
8. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995 ; 311 : 899-909.
9. Scagliotti GV, Fossati R, Torri V, Crino L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M :Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003 ; 95 : 1453-61.
10. Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG : Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 2004 ; 26 : 173-82.
11. Douillard JY, Rosell R, Delena M, Le Groumelec A, Carparano F : ANITA/ phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stageI-III) non-smallcell lung cancer (NSCLC) patients (pts): Final results after 70 month follow-up. On behalf of the Adjuvant Navelbine International Trialists Association. J Clin Oncol 2005 ; 23 : 16S (suppl; abstr 7013).
12. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, Cormier Y, Goss G, Inculet R, Vallieres E, Fry W, Bethune D, Ayoub J, Ding K, Seymour L, Graham B, Tsao MS, Gandara D, Kesler K, Demmy T, Shepherd F : National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005 ; 352 : 2589-97.
13. Strauss GM, Herdon J, Maddaus MA, Johnstone DW, Johnson EA, Watson DM, Sugarbaker DJ, Schilsky RL, Green MR : Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. J Clin Oncol 2004 ; 22 : 621s (suppl; abstr 7019).
14. Strauss GM, Herndon JE, Maddaus MA, Johnstone DW, Johnson EA, Watson DM, Sugarbaker DJ, Schilsky RA, Vokes EE, Green MR, a. for the CALGB, Radiation Therapy Oncology Group : Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 2006 ASCO Annual Meeting Proceedings 24, No. 18S, 2006 : 7007.
15. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J, International Adjuvant Lung Cancer Trial Collaborative Group : Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004 ; 350 : 351-60.
16. Blum RH : Adjuvant chemotherapy for lung cancer - a new standard of care. N Engl J Med 2004 ; 350 : 404-5.
17. Johnson BE : Adjuvant chemotherapy for non-small-cell lung cancer: the end of the beginning. J Natl Cancer Inst 2003 ; 95 : 1422-4.
18. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH, Eastern Cooperative Oncology Group : Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002 ; 346 : 92-8.
19. Aaronson NK, Ahmedzai S, Bergman B Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F : The European Organization for Research and Treatment of Cancer QLQ-C30 : a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 ; 85 : 365-76.
20. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M : The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 1994 ; 30A : 635-42.
21. Cull A, Sprangers MAG, Bjordal K , Aaronson N : EORTC Qua-lity of Life Study Group Translation Procedure. Brussels, Belgium, European Organization For Research and Treatment of Cancer, 1998.
22. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J : Psychometric properties and responsiveness of the EORTC quality of life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994 ; 3 : 353-64.
23. Osoba D, Rodrigues G, Myles J, Zee B, Pater J : Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998 ; 16 : 139-44.
24. Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK : The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules : an update and overview. EORTC Quality of Life Study Group. Qual Life Res 1998 ; 7 : 291-300.
25. Goodyear MDE, Fraumeni MA : Incorporating quality of life assessment into clinical cancer trials. In: Quality of life and pharmacoeconomics in clinical trials. Spilker B, eds. Lippincott-Raven, Philadelphia 1996 ; 1003-13.
26. Leplège A, Mesbah M, Marquis P : Résultats préliminaires des propriétés psychométriques de la version française d'un questionnaire international de mesure de la qualité de vie: le MOS SF-36 (version 1.1). Rev Epidémiol Santé Publique 1995 ; 43 : 371-9.
27. Leplège A, Ecosse E, Verdier A, Perneger TV : The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998 ; 51 : 1013-23.
28. Ginsberg RJ, Rubinstein LV : Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995 ; 60 : 615-22.
29. Vogt-Moykopf I, Toomes H, Heinrich S : Sleeve resection of the bronchus and pulmonary artery for pulmonary lesions. J Thorac Cardiovasc Surg 1983 ; 31 : 193-8.
30. Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H, Satake S, Yamagishi H : Extended sleeve lobectomy for lung cancer: the avoidance of pneumonectomy. J Thorac Cardiovasc Surg 1999 ; 118 : 710-3.
31. Lausberg HF, Graeter TP, Wendler O, Demertzis S, Ukena D, Schafers HJ : Bronchial and bronchovascular sleeve resection for treatment of central lung tumors. Ann Thorac Surg 2000 ; 70 : 367-71.
32. Doddoli C, Thomas P, Thirion X, Seree Y, Giudicelli R, Fuentes P : Postoperative complication in relation to induction therapy for lung cancer. Eur J Cardiothorac Surg 2001 ; 20 : 385-90.
33. Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, Weigel TL, Kris MG, Venkatraman ES, Rusch VW : Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 2001 ; 72 : 1149-54.
34. Kirby TJ, Mack MJ, Landreneau RJ, Rice TW : Lobectomy-video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg 1995 ; 109 : 997-1001.
35. Yi-long Wu, Zhi-fan Huang, Si-yu Wang, Xue-ning Yang, Wei Ou : A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung cancer 2002 ; 36 : 1-6.
36. Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, Kaneda Y, Esato K : Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 1998 ; 22 : 290-4.
37. Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, Thetter O : Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 1998 ; 227 : 138-44.
38. Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR : Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases - results of a preliminary study. Eur J Cardiothorac Surg 2002 ; 21 : 520-6.
39. Wu Y, Wang S, Huang Z : Extent of lymphadenectomy in stage I-IIIA non-small cell lung cancer : a randomized clinical trial Zhonghua Zhong Liu Za Zhi. 2001 ; 23 : 43-5
40. American Joint Committee on Cancer : AJCC Cancer Staging Manual (ed 6). New York, NY, Springer, 2002.
41. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL : Effect of number of lymph nodes sampled on outcome in patients with stage I non small-cell lung cancer. J Clin Oncol 2003 ; 21 : 1029-34.